A SECOND “game-changing” Alzheimer’s drug shown to slow the progression of the disease has been approved in the UK. Donanemab, developed by pharmaceutical giant Eli Lilly, was ...
As a child of the 1970s, a tearful Native American featured in an anti-litter TV ad will forever be engrained in my memory. Fifty years later ... spectators left our local high school football game, I ...
The research is a close collaboration between Mass General Hospital and community groups. Both Roxbury-based The Wellness Collaborative and Cambridge-based Community Conversations: Sister to Sister ...